Back to journals
Academic Journal

Current Opinion in Behavioral Sciences

2 Papers Indexed in Blossom

Data updated

Research Footprint

Current Opinion in Behavioral Sciences has 2 tracked papers indexed in Blossom (2017–2018) from 7 authors, most often covering Ketamine, Psilocybin and Ibogaine, across Depressive Disorders, Substance Use Disorders (SUD) and Major Depressive Disorder (MDD).

Published Papers

Paywallmeta

Sex differences in sub-anesthetic ketamine’s antidepressant effects and abuse liability

This review (2018) examines gender-related differences related to antidepressant effects and abuse liability of ketamine given that women are twice as likely to develop depression and progress through the stages of addiction faster than men. Preclinical evidence suggests that female rats are indeed more sensitive to ketamine’s effects, but more clinical research is needed to verify these gender-related effects in humans.

Published
Journal
Current Opinion in Behavioral Sciences
Authors
Wright, K. N., Kabbaj, M.
Paywallmeta

Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use

This review (2017) looks at the (preliminary) evidence that we have of psychedelics in the treatment of addictions (AUD, SUD). Trials with psilocybin, ibogaine, ayahuasca, ketamine (etc) are showing positive results, but randomised controlled trials (RCTs) are badly needed.

Published
Journal
Current Opinion in Behavioral Sciences
Authors
Morgan, C. J. A., McAndrew, A., Stevens, T., Nutt, D. J., Lawn, W.

Quick Facts

Papers Indexed
2
h-Index
85
Open Access
No
Publisher
Elsevier
Country
United Kingdom
Website
Visit